StrideBio
StrideBio, based in Durham, NC, focuses on developing advanced gene therapies for life-threatening diseases, utilizing its STRIVETM Capsid Platform and AAV Manufacturing.
Company Overview
StrideBio is a company based in Durham, NC, focused on leading the next evolution in gene therapy. The organization is committed to developing best-in-class gene therapies designed for individuals suffering from life-threatening diseases. StrideBio aims to be recognized as a leader in evolving gene therapy, renowned for superior drug development, high industry standards, extraordinary integrity, and an innovative team dedicated to translating science into life-prolonging and life-improving treatments.
Therapeutic Pipeline
StrideBio offers a therapeutic pipeline aimed at addressing a variety of life-threatening diseases through advanced gene therapy solutions. The company's pipeline is grounded in rigorous scientific research and development, providing innovative treatments intended to prolong and improve the quality of life for patients. This comprehensive pipeline demonstrates StrideBio's commitment to delivering high-quality, transformative therapies.
STRIVETM Capsid Platform
One of StrideBio's key offerings is the STRIVETM Capsid Platform. This cutting-edge platform is designed to enhance the delivery and efficacy of gene therapies. By utilizing this proprietary technology, StrideBio is able to create more targeted and effective treatments, addressing the complexities of gene therapy. The platform is a testament to the company's dedication to innovation and excellence in the field.
AAV Manufacturing
StrideBio provides AAV (Adeno-Associated Virus) Manufacturing as part of its suite of gene therapy solutions. This service enables the production of high-quality viral vectors that are essential for effective gene therapy treatments. StrideBio's manufacturing capabilities ensure that their gene therapy products meet the highest standards of quality and reliability, reinforcing their commitment to industry-leading practices.
Location - Durham, NC
StrideBio is strategically located in Durham, North Carolina, a hub for biotech innovation and research. This location provides the company with access to top-tier scientific talent, research facilities, and a collaborative environment that fosters advancements in gene therapy. Being in Durham allows StrideBio to leverage a strong network of industry partners and resources, supporting their mission to develop life-saving gene therapies.